Current Opening
Home
Current Opening
OUR FOCUSED PRODUCTS PORTFOLIO
Quality Healthcare Across Key Therapeutic Areas
Explore our diverse range of pharmaceutical products, developed across major therapeutic categories to address evolving healthcare needs. From everyday healthcare solutions to specialized therapies, our portfolio reflects our commitment to quality, reliability, and accessible healthcare for patients across India.
Financial Year Reports
Annual Reports
01
Transcript of the 35th Annual General Meeting
02
Voting Results and Scrutinizer’s Consolidated Report for 35th AGM
03
Webcast Link of AGM of Mankind Scheduled for August 4, 2026
04
Business Responsibility & Sustainability Report for F.Y. 2025-26
05
Disclosure under Regulation 14 of SEBI (SBEB) Regulations
06
Draft Annual Return F.Y. 2025-26
07
Notice of the 35th Annual General Meeting
08
Annual Report for FY 2025-26
01
Transcript of the 35th Annual General Meeting
02
Voting Results and Scrutinizer’s Consolidated Report for 35th AGM
03
Webcast Link of AGM of Mankind Scheduled for August 4, 2026
04
Business Responsibility & Sustainability Report for F.Y. 2025-26
05
Disclosure under Regulation 14 of SEBI (SBEB) Regulations
06
Draft Annual Return F.Y. 2025-26
07
Notice of the 35th Annual General Meeting
08
Annual Report for FY 2025-26
01
Transcript of the 35th Annual General Meeting
02
Voting Results and Scrutinizer’s Consolidated Report for 35th AGM
03
Webcast Link of AGM of Mankind Scheduled for August 4, 2026
04
Business Responsibility & Sustainability Report for F.Y. 2025-26
05
Disclosure under Regulation 14 of SEBI (SBEB) Regulations
06
Draft Annual Return F.Y. 2025-26
07
Notice of the 35th Annual General Meeting
08
Annual Report for FY 2025-26
01
Transcript of the 35th Annual General Meeting
02
Voting Results and Scrutinizer’s Consolidated Report for 35th AGM
03
Webcast Link of AGM of Mankind Scheduled for August 4, 2026
04
Business Responsibility & Sustainability Report for F.Y. 2025-26
05
Disclosure under Regulation 14 of SEBI (SBEB) Regulations
06
Draft Annual Return F.Y. 2025-26
07
Notice of the 35th Annual General Meeting
08